Filing Details
- Accession Number:
- 0001203311-13-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-17 20:12:14
- Reporting Period:
- 2013-01-15
- Filing Date:
- 2013-01-17
- Accepted Time:
- 2013-01-17 20:12:14
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1060736 | Seattle Genetics Inc | SGEN | Biological Products, (No Disgnostic Substances) (2836) | 911874389 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1393945 | C Thomas Reynolds | 21823 30Th Drive Se Bothell WA 98021 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-01-15 | 3,679 | $11.09 | 61,280 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 3,679 | $28.01 | 57,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-15 | 35,492 | $11.09 | 93,093 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 35,492 | $28.00 | 57,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-15 | 35,493 | $11.09 | 93,094 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 35,493 | $28.00 | 57,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-15 | 33,643 | $12.16 | 91,244 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 33,643 | $28.01 | 57,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-15 | 12,605 | $12.00 | 70,206 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 12,605 | $28.01 | 57,601 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-01-15 | 4,167 | $15.46 | 61,768 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-01-15 | 4,167 | $28.01 | 57,601 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Incentive Stock Option (right to buy) | Disposition | 2013-01-15 | 3,679 | $0.00 | 3,679 | $11.09 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-15 | 35,492 | $0.00 | 35,492 | $11.09 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-15 | 35,493 | $0.00 | 35,493 | $11.09 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-15 | 12,605 | $0.00 | 12,605 | $12.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-15 | 33,643 | $0.00 | 33,643 | $12.16 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2013-01-15 | 4,167 | $0.00 | 4,167 | $15.46 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2018-08-27 | No | 4 | M | Direct | |
35,493 | 2018-08-27 | No | 4 | M | Direct | |
0 | 2018-08-27 | No | 4 | M | Direct | |
43,751 | 2020-08-27 | No | 4 | M | Direct | |
12,611 | 2019-08-25 | No | 4 | M | Direct | |
60,199 | 2021-08-24 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on December 13, 2012.
- $28.0058 represents an average price per share for the shares sold on 1/15/2013. The sell price for shares sold on this day ranged from $27.36 to 28.27.
- Amount of securities beneficially owned following reported transactions includes 53,886 Restricted Stock Units subject to vesting.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on November 8, 2011.
- Shares vested at a rate of 25% on 8/27/09 and monthly thereafter until all the shares were fully vested on 8/27/12.
- Shares shall vest at a rate of 25% on 8/27/11 and monthly thereafter until all the shares are fully vested on 8/27/14.
- Shares shall vest at a rate of 25% on 8/25/10 and monthly thereafter until all the shares are fully vested on 8/25/13.
- Shares shall vest at a rate of 25% on 8/24/12 and monthly thereafter until all the shares are fully vested on 8/24/15.